What's your position on ?
Why are you ish?
You voted ish on Vote again
Posts appear on the My Feed page of subscribers to this ticker
- View all 5 replies
MtBudmoreView + Follow Following - Unfollow | Send Message 11 Jan: thanksJan 11, 12:04 PM
MtBudmoreView + Follow Following - Unfollow | Send Message 20 Jan: X if lxu can survive the trauma, do you think the pieces can come back togetherJan 20, 2:54 AM
Akebia Therapeutics, Inc. is a biopharmaceutical company, which focuses on development of novel proprietary therapeutics based on hypoxia-inducible factor biology and the commercialization of these products for patients with kidney disease. Its lead product candidate, AKB-6548, is in a Phase 2b... More
Country: United States
at Zacks.com (Apr 13, 2016)
at Zacks.com (Apr 5, 2016)
Akebia Announces Presentations at the Upcoming American Society of Nephrology Kidney Week 2015 Annual Meetingat 4-traders.com (Oct 28, 2015)
Akebia Therapeutics : Rosen Law Firm Announces Investigation of Securities Claims Against Akebia Therapeutics, Inc. - AKBAat 4-traders.com (Oct 8, 2015)
Other News & PR